Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Intangibles (2020)

Historic Change in Intangibles for Vanda Pharmaceuticals (VNDA) over the last 3 years, with Q1 2020 value amounting to $37.5 million.

  • Vanda Pharmaceuticals' Change in Intangibles changed N/A to $37.5 million in Q1 2020 from the same period last year, while for Mar 2020 it was $37.5 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2018, which is N/A changed from last year.
  • Vanda Pharmaceuticals' Change in Intangibles amounted to $37.5 million in Q1 2020.
  • Vanda Pharmaceuticals' Change in Intangibles' 5-year high stood at $37.5 million during Q1 2020, with a 5-year trough of $37.5 million in Q1 2020.